Back to Search
Start Over
Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases.
- Source :
-
Annals of translational medicine [Ann Transl Med] 2023 Mar 31; Vol. 11 (6), pp. 273. Date of Electronic Publication: 2023 Jan 16. - Publication Year :
- 2023
-
Abstract
- Competing Interests: Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-2022-78/coif). PR has received honoraria for lectures and Advisory Boards from BMS, MSD, Novartis, Pierre Fabre, Sanofi, Merck, Astra Zeneca and Philogen outside of the scope of this manuscript. AMC has received honoraria for presentations, speakers bureaus and support for attending meetings from BMS, MSD, Novartis and Pierre Fabre.
Details
- Language :
- English
- ISSN :
- 2305-5839
- Volume :
- 11
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Annals of translational medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 37082659
- Full Text :
- https://doi.org/10.21037/atm-2022-78